Evidence map›Paper›PMID 17202315›Full record

ArticleBlood2007

Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions.

Kulandayan K Subramanian, Yonghui Jia, Daocheng Zhu, Benjamin T Simms, Hakryul Jo, Hidenori Hattori, Jian You, Joseph P Mizgerd, Hongbo R Luo

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Blood, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Future microbiology · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. PTEN in Immunity.Current topics in microbiology and immunology · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. The Role of PTEN in Innate and Adaptive Immunity.Cold Spring Harbor perspectives in medicine · 2019
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. PTEN Inhibition in Human Disease Therapy.Molecules (Basel, Switzerland) · 2018
    Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kulandayan K SubramanianDepartment of Pathology, Harvard Medical School, Boston, MA, USA.
Yonghui Jia
Daocheng Zhu
Benjamin T Simms
Hakryul Jo
Hidenori Hattori
Jian You
Joseph P Mizgerd
Hongbo R Luo
Harvard University · USBoston Children's Hospital · US

Funding

TRANSFUSION BIOLOGY AND MEDICINET32HL066987 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI JOHN P MANIS · 2001 to 2026
$10.2M
NF-KB and Innate Immunity in the LungsR01HL068153 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI MIZGERD, JOSEPH P · 2003 to 2016
$5.1M
Regulation and function of STAT3 during pneumoniaR01HL079392 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI MIZGERD, JOSEPH P · 2005 to 2015
$4.0M
Signal transduction in neutrophil chemotaxisR01GM076084 · NIGMS · BOSTON CHILDREN'S HOSPITAL · PI LUO, HONGBO R · 2006 to 2010
$1.5M
InsP7 in glutamate excitotoxicityR21NS052200 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI LUO, HONGBO R · 2005 to 2006
$424k
NHLBI NIH HHS HL 066987NHLBI NIH HHS HL 068153NHLBI NIH HHS HL 079392NHLBI NIH HHS R01 HL068153NHLBI NIH HHS R01 HL079392NHLBI NIH HHS T32 HL066987NIGMS NIH HHS GM 076084NIGMS NIH HHS R01 GM076084NINDS NIH HHS NS 052200NINDS NIH HHS R21 NS052200
6 · The paper itself

Abstract

The recruitment and activation of neutrophils at infected tissues is essential for host defense against invading microorganisms. However, excessive neutrophil recruitment or activation can also damage the surrounding tissues and cause unwanted inflammation. Hence, the responsiveness of neutrophils needs to be tightly regulated. In this study, we have investigated the functional role of tumor suppressor PTEN in neutrophils by using a mouse line in which PTEN is disrupted only in myeloid-derived cells. Chemoattractant-stimulated PTEN(-/-) neutrophils displayed significantly higher Akt phosphorylation and actin polymerization. A larger fraction of these neutrophils displayed membrane ruffles in response to chemoattractant stimulation. In addition, chemoattractant-induced transwell migration and superoxide production were also augmented. Single-cell chemotaxis assays showed that PTEN(-/-) neutrophils have a small (yet statistically significant) defect in directionality. However, these neutrophils also showed an increase in cell speed. As a result, overall chemotaxis, which depends on speed and directionality, was not affected. Consistent with the increased responsiveness of PTEN(-/-) neutrophils, the in vivo recruitment of these cells to the inflamed peritoneal cavity was significantly enhanced. Thus, as a physiologic-negative regulator, PTEN should be a promising therapeutic target for modulating neutrophil functions in various infectious and inflammatory diseases.

Indexed as

AnimalsCell LineChemotactic FactorsChemotaxis, LeukocyteInflammationMiceMice, KnockoutNeutrophil InfiltrationNeutrophilsProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseChemotactic FactorsProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePten protein, mouse

Identifiers

PMID17202315
PMCPMC1874585
OpenAlexW2023661694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.